Tag Archives: P2P

Mary Dimmock: Fight the Power

The draft P2P evidence review report has been issued and we have all had a chance to see just how appallingly bad it is. Now the question is what to do next. Some have called for us to oppose P2P … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 42 Comments

Draft Systematic Review is UP

The draft systematic evidence review on the Diagnosis and Treatment of ME/CFS has been published. This review is extraordinarily important because it is being presented to the P2P Panel in a closed door session any day now. This review will … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | 7 Comments

P2P Participation, Part 2

I have new information on participation in the Pathways to Prevention ME/CFS Workshop: The Office of Disease Prevention confirmed via telephone that the public will be able to participate in discussion at the P2P Workshop, in person and online. ODP … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , | 14 Comments

Why You Should P2P

My concerns about the NIH’s Pathways to Prevention Workshop on ME/CFS are legion, and I’ve been quite vocal about them. But today I am asking you to participate in the P2P Workshop on December 9-10, 2014. Registration for attending in … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 35 Comments

La La La, I Can’t Hear You

On May 28th, Mary Dimmock and I sent NIH Director Dr. Francis Collins a 38 page packet outlining our concerns that the P2P Workshop will not advance the ME/CFS research field, and may even set it back. We finally got … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 19 Comments

P2P: The Question They Will Not Ask

by Mary Dimmock and Jennie Spotila The most important question about ME/CFS – the question that is the cornerstone for every aspect of ME/CFS science – is the question that the P2P Workshop will not ask: How do ME and … Continue reading

Posted in Advocacy, Commentary, Research | Tagged , , , , , , , , , | 38 Comments

Parsing CFSAC

I feel like a broken record, saying that the June 16-17th CFS Advisory Committee meeting was frustrating. This meeting struck me as a tangle of threads that can only be understood by teasing them apart. There were signals buried in … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , , , | 17 Comments

P2P: Taking Shape

The P2P ME/CFS Workshop has been approved and is scheduled for December 9-10th, 2014. The focus of this post is on analyzing four components of the information released by NIH yesterday: P2P is describing our disease as fatigue, without post-exertional … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , , , , | 13 Comments

Guest Post: CFSAC Comments of Charmian Proskauer

Charmian delivered these comments at today’s CFS Advisory Committee meeting. She has kindly given me permission to publish them here in their entirety. My name is Charmian Proskauer, and I currently serve as President of the Massachusetts CFIDS/ME & FM … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 1 Comment

Comment for the June 2014 CFS Advisory Committee

These are the comments I delivered by telephone to the CFS Advisory Committee today. For the record, the operator told me that they were instructed to cut people off precisely at 3 minutes. Mary Dimmock and I wrote to Dr. … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 2 Comments